BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ormandy LA, Färber A, Cantz T, Petrykowska S, Wedemeyer H, Hörning M, Lehner F, Manns MP, Korangy F, Greten TF. Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma. World J Gastroenterol 2006; 12(20): 3275-3282 [PMID: 16718852 DOI: 10.3748/wjg.v12.i20.3275]
URL: https://www.wjgnet.com/1948-5182/full/v12/i20/3275.htm
Number Citing Articles
1
Ekaterina Breous, Robert Thimme. Potential of immunotherapy for hepatocellular carcinomaJournal of Hepatology 2011; 54(4): 830 doi: 10.1016/j.jhep.2010.10.013
2
Jingnan Xu, Zhuo Song, Qiujun Guo, Jie Li. Synergistic Effect and Molecular Mechanisms of Traditional Chinese Medicine on Regulating Tumor Microenvironment and Cancer CellsBioMed Research International 2016; 2016: 1 doi: 10.1155/2016/1490738
3
Fang Zhao, Christine Falk, Wolfram Osen, Masashi Kato, Dirk Schadendorf, Viktor Umansky. Activation of p38 Mitogen-Activated Protein Kinase Drives Dendritic Cells to Become Tolerogenic in Ret Transgenic Mice Spontaneously Developing MelanomaClinical Cancer Research 2009; 15(13): 4382 doi: 10.1158/1078-0432.CCR-09-0399
4
Vito Longo, Antonio Gnoni, Andrea Casadei Gardini, Salvatore Pisconti, Antonella Licchetta, Mario Scartozzi, Riccardo Memeo, Vincenzo Ostilio Palmieri, Giuseppe Aprile, Daniele Santini, Patrizia Nardulli, Nicola Silvestris, Oronzo Brunetti. Immunotherapeutic approaches for hepatocellular carcinomaOncotarget 2017; 8(20): 33897 doi: 10.18632/oncotarget.15406
5
Kyle K. Payne, Hussein F. Aqbi, Savannah E. Butler, Laura Graham, Rebecca C. Keim, Wen Wan, Michael O. Idowu, Harry D. Bear, Xiang‐Yang Wang, Masoud H. Manjili. Gr1 −/low CD11b −/low MHCII + myeloid cells boost T cell anti‐tumor efficacy Journal of Leukocyte Biology 2018; 104(6): 1215 doi: 10.1002/JLB.5A0717-276RR
6
Dmitry I. Gabrilovich, Suzanne Ostrand-Rosenberg, Vincenzo Bronte. Coordinated regulation of myeloid cells by tumoursNature Reviews Immunology 2012; 12(4): 253 doi: 10.1038/nri3175
7
Annalisa Legitimo, Rita Consolini, Alessandra Failli, Giulia Orsini, Roberto Spisni. Dendritic cell defects in the colorectal cancerHuman Vaccines & Immunotherapeutics 2014; 10(11): 3224 doi: 10.4161/hv.29857
8
Nathalie Schmidt, Christoph Neumann-Haefelin, Robert Thimme. Cellular Immune Responses to Hepatocellular Carcinoma: Lessons for ImmunotherapyDigestive Diseases 2012; 30(5): 483 doi: 10.1159/000341697
9
Benjamin Ruf, Bernd Heinrich, Tim F. Greten. Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cellsCellular & Molecular Immunology 2021; 18(1): 112 doi: 10.1038/s41423-020-00572-w
10
Giulia Orsini, Annalisa Legitimo, Alessandra Failli, Paola Ferrari, Andrea Nicolini, Roberto Spisni, Paolo Miccoli, Rita Consolini. Defective Generation and Maturation of Dendritic Cells from Monocytes in Colorectal Cancer Patients during the Course of DiseaseInternational Journal of Molecular Sciences 2013; 14(11): 22022 doi: 10.3390/ijms141122022
11
Melissa Borgia, Michele Dal Bo, Giuseppe Toffoli. Role of Virus-Related Chronic Inflammation and Mechanisms of Cancer Immune-Suppression in Pathogenesis and Progression of Hepatocellular CarcinomaCancers 2021; 13(17): 4387 doi: 10.3390/cancers13174387
12
Mariam Mroweh, Thomas Decaens, Patrice N Marche, Zuzana Macek Jilkova, Flora Clément. Modulating the Crosstalk between the Tumor and Its Microenvironment Using RNA Interference: A Treatment Strategy for Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2020; 21(15): 5250 doi: 10.3390/ijms21155250
13
Suresh Kalathil, Amit A. Lugade, Austin Miller, Renuka Iyer, Yasmin Thanavala. Higher Frequencies of GARP+CTLA-4+Foxp3+ T Regulatory Cells and Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Are Associated with Impaired T-Cell FunctionalityCancer Research 2013; 73(8): 2435 doi: 10.1158/0008-5472.CAN-12-3381
14
Jana C Mossanen, Frank Tacke. Role of lymphocytes in liver cancerOncoImmunology 2013; 2(11): e26468 doi: 10.4161/onci.26468
15
Silvia Martin Lluesma, Michele Graciotti, Cheryl Chiang, Lana Kandalaft. Does the Immunocompetent Status of Cancer Patients Have an Impact on Therapeutic DC Vaccination Strategies?Vaccines 2018; 6(4): 79 doi: 10.3390/vaccines6040079
16
Angela D. Pardee, Jian Shi, Lisa H. Butterfield. Tumor-Derived α-Fetoprotein Impairs the Differentiation and T Cell Stimulatory Activity of Human Dendritic CellsThe Journal of Immunology 2014; 193(11): 5723 doi: 10.4049/jimmunol.1400725
17
Yu-Peng Hong, Zi-Duo Li, Pankaj Prasoon, Qi Zhang. Immunotherapy for hepatocellular carcinoma: From basic research to clinical useWorld Journal of Hepatology 2015; 7(7): 980-992 doi: 10.4254/wjh.v7.i7.980
18
Viktor Umansky, Dirk Schadendorf. Dendritic Cells in Cancer2009; : 89 doi: 10.1007/978-0-387-88611-4_6
19
Yang Ma, Galina V. Shurin, Dmitriy W. Gutkin, Michael R. Shurin. Tumor associated regulatory dendritic cellsSeminars in Cancer Biology 2012; 22(4): 298 doi: 10.1016/j.semcancer.2012.02.010
20
Jyh-Chiang E. Wang, James J. Kobie, Li Zhang, Matthew Cochran, Tim R. Mosmann, Christopher T. Ritchlin, Sally A. Quataert. An 11-color flow cytometric assay for identifying, phenotyping, and assessing endocytic ability of peripheral blood dendritic cell subsets in a single platformJournal of Immunological Methods 2009; 341(1-2): 106 doi: 10.1016/j.jim.2008.11.002
21
Tobias Flecken, Hans Christian Spangenberg, Robert Thimme. Immunobiology of hepatocellular carcinomaLangenbeck's Archives of Surgery 2012; 397(5): 673 doi: 10.1007/s00423-011-0783-x
22
Differential ratios of fish/corn oil ameliorated the colon carcinoma in rat by altering intestinal intraepithelial CD8+ T lymphocytes, dendritic cells population and modulating the intracellular cytokinesBiomedicine & Pharmacotherapy 2018; 98: 600 doi: 10.1016/j.biopha.2017.12.041
23
Michael R. Shurin, Anton A. Keskinov. Encyclopedia of Immunobiology2016; : 499 doi: 10.1016/B978-0-12-374279-7.17014-6
24
Suzanne Ostrand-Rosenberg, Pratima Sinha, Daniel W. Beury, Virginia K. Clements. Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppressionSeminars in Cancer Biology 2012; 22(4): 275 doi: 10.1016/j.semcancer.2012.01.011
25
Tobias Flecken, Robert Thimme. Hepatocellular Carcinoma2016; : 199 doi: 10.1007/978-3-319-34214-6_13
26
Stefania Mantovani, Barbara Oliviero, Andrea Lombardi, Stefania Varchetta, Dalila Mele, Angelo Sangiovanni, Giorgio Rossi, Matteo Donadon, Guido Torzilli, Cristiana Soldani, Camillo Porta, Paolo Pedrazzoli, Silvia Chiellino, Roberto Santambrogio, Enrico Opocher, Marcello Maestri, Stefano Bernuzzi, Armando Rossello, Sophie Clément, Claudio De Vito, Laura Rubbia-Brandt, Francesco Negro, Mario U. Mondelli. Deficient Natural Killer Cell NKp30-Mediated Function and Altered NCR3 Splice Variants in Hepatocellular CarcinomaHepatology 2019; 69(3): 1165 doi: 10.1002/hep.30235
27
Giulia Orsini, Annalisa Legitimo, Alessandra Failli, Paola Ferrari, Andrea Nicolini, Roberto Spisni, Paolo Miccoli, Rita Consolini. Quantification of Blood Dendritic Cells in Colorectal Cancer Patients During the Course of DiseasePathology & Oncology Research 2014; 20(2): 267 doi: 10.1007/s12253-013-9691-4
28
Seo-Young Koo, Eun-Ji Park, Chang-Woo Lee. Immunological distinctions between nonalcoholic steatohepatitis and hepatocellular carcinomaExperimental & Molecular Medicine 2020; 52(8): 1209 doi: 10.1038/s12276-020-0480-3
29
Xiaopei Hao, Guangshun Sun, Yao Zhang, Xiangyi Kong, Dawei Rong, Jinhua Song, Weiwei Tang, Xuehao Wang. Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and ChallengesFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.775462
30
Zhengkun Tu, Heli K. Hamalainen-Laanaya, Chiaki Nishitani, Yoshio Kuroki, Ian Nicholas Crispe, Mark S. Orloff. HCV core and NS3 proteins manipulate human blood-derived dendritic cell development and promote Th 17 differentiationInternational Immunology 2012; 24(2): 97 doi: 10.1093/intimm/dxr104
31
Beatriz Subtil, Alessandra Cambi, Daniele V. F. Tauriello, I. Jolanda M. de Vries. The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal CancerFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.724883
32
Maria Tagliamonte, Annacarmen Petrizzo, Maria Lina Tornesello, Gennaro Ciliberto, Franco M Buonaguro, Luigi Buonaguro. Combinatorial immunotherapy strategies for hepatocellular carcinomaCurrent Opinion in Immunology 2016; 39: 103 doi: 10.1016/j.coi.2016.01.005
33
Yuri Cho, Jimin Han, Won Kim. Recent Advances and Future Directions in Immunotherapeutics for Hepatocellular CarcinomaJournal of Liver Cancer 2019; 19(1): 1 doi: 10.17998/jlc.19.1.1
34
Sneha Mathew, Kristy L. Bauer, Arne Fischoeder, Nina Bhardwaj, Stephen J. Oliver. The Anergic State in Sarcoidosis Is Associated with Diminished Dendritic Cell FunctionThe Journal of Immunology 2008; 181(1): 746 doi: 10.4049/jimmunol.181.1.746
35
Rachel Grossman, Zvi Ram. Monocyte-Derived Cells of the Brain in Malignant GliomasWorld Neurosurgery 2014; 82(6): 1012 doi: 10.1016/j.wneu.2013.01.074
36
Alexandr V. Bazhin, Katharina von Ahn, Jasmin Fritz, Jens Werner, Svetlana Karakhanova. Interferon-α Up-Regulates the Expression of PD-L1 Molecules on Immune Cells Through STAT3 and p38 SignalingFrontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.02129
37
Denise A. Caruso, Sarah Fraser, Kellie Hardy, Gerlinda Amor, Jorinde J. Helmich, David M. Ashley. Costimulation molecule expression and subset distribution of blood dendritic cells in normal children and newly diagnosed pediatric leukemia and lymphoma patientsExperimental Hematology 2008; 36(12): 1691 doi: 10.1016/j.exphem.2008.07.003
38
Alexandre Harari, Michele Graciotti, Michal Bassani-Sternberg, Lana E. Kandalaft. Antitumour dendritic cell vaccination in a priming and boosting approachNature Reviews Drug Discovery 2020; 19(9): 635 doi: 10.1038/s41573-020-0074-8
39
Junfei Jin, Pengpeng Zhu, Yan Liao, Jun Li, Weijia Liao, Songqing He. Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resectionOncotarget 2015; 6(22): 19217 doi: 10.18632/oncotarget.4265
40
XINLI HUANG, JIANJIE QIN, SEN LU. Kanglaite stimulates anticancer immune responses and inhibits HepG2 cell transplantation-induced tumor growthMolecular Medicine Reports 2014; 10(4): 2153 doi: 10.3892/mmr.2014.2479
41
Takahiro Kodama, Tetsuo Takehara. Liver Immunology2020; : 505 doi: 10.1007/978-3-030-51709-0_31
42
Rachel Kerr. Immunotherapy for Gastrointestinal Cancer2017; : 1 doi: 10.1007/978-3-319-43063-8_1
43
Tim F. Greten, Michael P. Manns, Firouzeh Korangy. Immunotherapy of hepatocellular carcinomaJournal of Hepatology 2006; 45(6): 868 doi: 10.1016/j.jhep.2006.09.004
44
Michael R. Shurin, Gurkamal S. Chatta. Tumor-Induced Immune Suppression2008; : 101 doi: 10.1007/978-0-387-69118-3_6
45
S M Wörmann, K N Diakopoulos, M Lesina, H Algül. The immune network in pancreatic cancer development and progressionOncogene 2014; 33(23): 2956 doi: 10.1038/onc.2013.257
46
Izabela Łapuć, Andrzej Eljaszewicz, Janusz Kłoczko, Marcin Moniuszko. Rola monocytów w patogenezie przewlekłej białaczki limfocytowejActa Haematologica Polonica 2014; 45(4): 340 doi: 10.1016/j.achaem.2014.06.001
47
Annabelle Vogt, Elisabeth Sievers, Veronika Lukacs-Kornek, Georges Decker, Esther Raskopf, Nadja Meumann, Hildegard Büning, Tilman Sauerbruch, Christian P. Strassburg, Ingo G. H. Schmidt-Wolf, Maria A. Gonzalez-Carmona. Improving immunotherapy of hepatocellular carcinoma (HCC) using dendritic cells (DC) engineered to express IL-12 in vivo Liver International 2014; 34(3): 447 doi: 10.1111/liv.12284
48
Michael R. Shurin, Anton A. Keskinov, Gurkamal S. Chatta. Tumor-Induced Immune Suppression2014; : 151 doi: 10.1007/978-1-4899-8056-4_5
49
Angela D. Pardee, Lisa H. Butterfield. Immunotherapy of hepatocellular carcinomaOncoImmunology 2012; 1(1): 48 doi: 10.4161/onci.1.1.18344
50
Han Huang, Jiansong Fang, Xiude Fan, Tatsunori Miyata, Xiaoyue Hu, Lihe Zhang, Liangren Zhang, Yimin Cui, Zhenming Liu, Xiaoqin Wu. Advances in Molecular Mechanisms for Traditional Chinese Medicine Actions in Regulating Tumor Immune ResponsesFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01009
51
Patricia M. Santos, Ashley V. Menk, Jian Shi, Allan Tsung, Greg M. Delgoffe, Lisa H. Butterfield. Tumor-Derived α-Fetoprotein Suppresses Fatty Acid Metabolism and Oxidative Phosphorylation in Dendritic CellsCancer Immunology Research 2019; 7(6): 1001 doi: 10.1158/2326-6066.CIR-18-0513
52
Bastian Hoechst, Lars A. Ormandy, Matthias Ballmaier, Frank Lehner, Christine Krüger, Michael P. Manns, Tim F. Greten, Firouzeh Korangy. A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T CellsGastroenterology 2008; 135(1): 234 doi: 10.1053/j.gastro.2008.03.020
53
Kohei Shigeta, Tai Hato, Yunching Chen, Dan G. Duda. Immunotherapy of Hepatocellular Carcinoma2017; : 85 doi: 10.1007/978-3-319-64958-0_6
54
Jianting Long, Bo Zhou, Heping Li, Qiangsheng Dai, Bing Zhang, Sizhong Xing, Zhirong Zeng, Wei Chen, Jianyong Yang. Improvement of HBsAg Gene-Modified Dendritic Cell-Based Vaccine Efficacy by Optimizing Immunization Method or the Application of β-glucosylceramideImmunological Investigations 2013; 42(2): 137 doi: 10.3109/08820139.2012.744418
55
Guangwen Shu, Tianming Yang, Chaoyuan Wang, Hanwen Su, Meixian Xiang. Gastrodin stimulates anticancer immune response and represses transplanted H22 hepatic ascitic tumor cell growth: Involvement of NF-κB signaling activation in CD4+ T cellsToxicology and Applied Pharmacology 2013; 269(3): 270 doi: 10.1016/j.taap.2013.02.019
56
YeunHwa Gu, Yoshiaki Fujimiya, Yuka Itokawa, Masami Oshima, Jung-Sook Choi, Toshihiro Miura, Torao Ishida. Tumoricidal Effects of β-Glucans: Mechanisms Include Both Antioxidant Activity Plus Enhanced Systemic and Topical ImmunityNutrition and Cancer 2008; 60(5): 685 doi: 10.1080/01635580802030884
57
Tim F. Greten, Michael P. Manns, Firouzeh Korangy. Myeloid derived suppressor cells in human diseasesInternational Immunopharmacology 2011; 11(7): 802 doi: 10.1016/j.intimp.2011.01.003
58
Minoru Kobayashi, Taro Kubo, Kenji Komatsu, Akira Fujisaki, Fumihito Terauchi, Shinsuke Natsui, Akinori Nukui, Shinsuke Kurokawa, Tatsuo Morita. Changes in peripheral blood immune cells: their prognostic significance in metastatic renal cell carcinoma patients treated with molecular targeted therapyMedical Oncology 2013; 30(2) doi: 10.1007/s12032-013-0556-1
59
Audry Fernández, Amaury Pupo, Karel Mena-Ulecia, Carlos Gonzalez. Pharmacological Modulation of Proton Channel Hv1 in Cancer Therapy: Future PerspectivesMolecular Pharmacology 2016; 90(3): 385 doi: 10.1124/mol.116.103804
60
James Yu, Vadim Zaytsev, Aimen Farooq, Anum Jalil, James Wert, Zohaib Ahmed, Sarfraz Ahmad. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 32022; : 245 doi: 10.1016/B978-0-323-99283-1.00022-7
61
Maria A. Gonzalez‐Carmona, Veronika Lukacs‐Kornek, Anne Timmerman, Sara Shabani, Miroslaw Kornek, Annabelle Vogt, Yildiz Yildiz, Elisabeth Sievers, Ingo G.H. Schmidt‐Wolf, Wolfgang H. Caselmann, Tilman Sauerbruch, Volker Schmitz. CD40ligand‐expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivoHepatology 2008; 48(1): 157 doi: 10.1002/hep.22296
62
Xiaoqin Zheng, Wenjie Jin, Shanshan Wang, Huiguo Ding. Progression on the Roles and Mechanisms of Tumor-Infiltrating T Lymphocytes in Patients With Hepatocellular CarcinomaFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.729705
63
Tim F. Greten, Firouzeh Korangy. Clinical Dilemmas in Primary Liver Cancer2011; : 191 doi: 10.1002/9781119962205.ch27
64
Tong Liu, Zhuhui Yuan, Hao Wang, Junjie Wang, Lixiang Xue. Peroxisome-Related Genes in Hepatocellular Carcinoma Correlated with Tumor Metabolism and Overall SurvivalClinics and Research in Hepatology and Gastroenterology 2021; : 101835 doi: 10.1016/j.clinre.2021.101835
65
Kouichi Momiyama, Hidenari Nagai, Yasukiyo Sumino. Changes of host immunity in relation to efficacy in liver cirrhosis patients with advanced hepatocellular carcinoma treated by intra-arterial chemotherapyCancer Chemotherapy and Pharmacology 2009; 64(2): 271 doi: 10.1007/s00280-008-0866-8
66
Firouzeh Korangy, Bastian Höchst, Michael P Manns, Tim F Greten. Immunotherapy of hepatocellular carcinomaExpert Review of Gastroenterology & Hepatology 2010; 4(3): 345 doi: 10.1586/egh.10.18
67
Bastian Hoechst, Torsten Voigtlaender, Lars Ormandy, Jaba Gamrekelashvili, Fei Zhao, Heiner Wedemeyer, Frank Lehner, Michael P. Manns, Tim F. Greten, Firouzeh Korangy. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptorHepatology 2009; 50(3): 799 doi: 10.1002/hep.23054
68
Antonio Saviano, Natascha Roehlen, Alessia Virzì, Armando Andres Roca Suarez, Yujin Hoshida, Joachim Lupberger, Thomas F. Baumert. Hepatocellular CarcinomaMolecular and Translational Medicine 2019; : 317 doi: 10.1007/978-3-030-21540-8_15
69
Sonja Obermann, Susanne Petrykowska, Michael P. Manns, Firouzeh Korangy, Tim F. Greten. Peptide-?2-microglobulin-major histocompatibility complex expressing cells are potent antigen-presenting cells that can generate specific T cellsImmunology 2007; 122(1): 90 doi: 10.1111/j.1365-2567.2007.02616.x